Alle Storys
Folgen
Keine Story von Sanacorp Pharmaholding AG mehr verpassen.

Sanacorp Pharmaholding AG

euro adhoc: Sanacorp Pharmaholding AG
Justice/Processes
Sanacorp: Business Combination with CERP Rouen
motion for an injunction

  Disclosure announcement transmitted by euro adhoc. The issuer is responsible
  for the content of this announcement.
06.11.2007
Altiro GmbH (former GEHE Gesundheitsdienste GmbH), domiciled in 
Stuttgart, applied for an injunction dated November 2, 2007 with the 
Regional Court Munich I which it had delivered by advance note today,
holding that Sanacorp Pharmaholding Aktiengesellschaft (former 
Sanacorp Pharmahandel Aktiengesellschaft, in the following 
"SANACORP") should be prohibited from assigning its investment in 
Sanacorp Pharmahandel GmbH to a third company, in particular a 
holding domiciled in Italy.
SANACORP has spun off its entire operating business to Sanacorp 
Pharmahandel GmbH which was formed on October 31, 2007 by entry of 
the spin-off in the commercial register. Within the scope of the 
planned business combination with French CERP Rouen SA (see our ad 
hoc statements dated January 30, 2007 and June 23, 2007), the 
investment of SANACORP in Sanacorp Pharmahandel GmbH is to be 
contributed to a joint venture which has already been established 
with CERP Rouen SA in Italy.
According to Altiro GmbH, SANACORP must, on the basis of existing 
agreements, offer them for purchase half of the block of shares 
totaling some 24.99 %, held now by Sanacorp Pharmahandel GmbH in 
Andreae-Noris Zahn AG, Frankfurt/Main, before the business 
combination will be realized; also, the above-mentioned contribution 
of the investment in Sanacorp Pharmahandel GmbH would thwart the 
rights of Altiro GmbH. SANACORP does not share this opinion, neither 
as regards the existence of a respective obligation nor as regards 
the alleged thwarting of rights due to the contribution and will 
therefore oppose the application for an injunction.
The regional court Munich I has already fixed a hearing date for 
November 15, 2007.
Planegg, November 5, 2007
Sanacorp Pharmaholding AG
The Management Board
end of announcement                               euro adhoc 06.11.2007 09:17:27

Further inquiry note:

Dr. Thomas Strieder
Telefon: +49(089) 8581 445
E-Mail: ir@sanacorp.de

Branche: Wholesale
ISIN: DE0007163131
WKN: 716313
Index: CDAX, Classic All Share, Prime All Share
Börsen: Börse Frankfurt / official dealing/prime standard
Börse Berlin / free trade
Börse Hamburg / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse München / official dealing